Monitoring disease activity using GH and IGF-I in the follow-up of 501 patients with acromegaly

Clinical Endocrinology

Volumn 71, Issue 1, 2009, Pages 74-81

  Sherlock, M ^a   Aragon Alonso, A ^a   Reulen, R C ^a   Ayuk, J ^a   Clayton, R N ^b   Holder, G ^c   Sheppard, M C ^a   Bates, A ^c   Stewart, P M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b KEELE UNIVERSITY   (United Kingdom)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ARTICLE; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE MARKER; FEMALE; FOLLOW UP; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME;

ACROMEGALY; ADULT; FEMALE; FOLLOW-UP STUDIES; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 66949149068     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03461.x     Document Type: Article

References (35)

1. Alexander, L., Appleton, D., Hall, R. et al. (1980) Epidemiology of acromegaly in the Newcastle region. Clinical Endocrinology, 12, 71 79. (Pubitemid 10174985)
2. Ayuk, J., Clayton, R.N., Holder, G. et al. (2004) Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 89, 1613 1617. (Pubitemid 38507910)
3. Bates, A.S., Van't Hoff, W., Jones, J.M. et al. (1993) An audit of outcome of treatment in acromegaly. Quarterly Journal of Medicine, 86, 293 299. (Pubitemid 23160830)
4. Beauregard, C., Truong, U., Hardy, J. et al. (2003) Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly. Clinical Endocrinology, 58, 86 91. (Pubitemid 36098853)
5. Nabarro, J.D. (1987) Acromegaly. Clinical Endocrinology, 26, 481 512. (Pubitemid 17036415)
6. Orme, S.M., McNally, R.J., Cartwright, R.A. et al. (1998) Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. Journal of Clinical Endocrinology and Metabolism, 83, 2730 2734.
7. Rajasoorya, C., Holdaway, I.M., Wrightson, P. et al. (1994) Determinants of clinical outcome and survival in acromegaly. Clinical Endocrinology, 41, 95 102. (Pubitemid 24232533)
8. Swearingen, B., Barker, F.G. 2nd, Katznelson, L. et al. (1998) Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. Journal of Clinical Endocrinology and Metabolism, 83, 3419 26.
9. Wright, A.D., Hill, D.M., Lowy, C. et al. (1970) Mortality in acromegaly. Quarterly Journal of Medicine, 39, 1 16.
10. Giustina, A., Barkan, A., Casanueva, F.F. et al. (2000) Criteria for cure of acromegaly: a consensus statement. Journal of Clinical Endocrinology and Metabolism, 85, 526 9.
11. Holdaway, I.M., Bolland, M.J. Gamble, G.D. (2008) A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. European Journal of Endocrinology, 159, 89 95.
12. Growth Hormone Research Society, Pituitary Society (2004) Biochemical assessment and long-term monitoring in patients with acromegaly: statement from a joint consensus conference of the Growth Hormone Research Society and the Pituitary Society. Journal of Clinical Endocrinology and Metabolism, 89, 3099 3102.
13. van der Lely, A.J., de Herder, W.W. Lamberts, S.W. (1997) The role of radiotherapy in acromegaly. Journal of Clinical Endocrinology and Metabolism, 82, 3185 3186.
14. Jenkins, P.J., Bates, P., Carson, M.N. et al. (2006) Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 91, 1239 1245.
15. Davis, J.R., Sheppard, M.C., Shakespear, R.A. et al. (1986) Does growth hormone releasing factor desensitize the somatotroph? Interpretation of responses of growth hormone during and after 10-h infusion of GRF 1-29 amide in man. Clinical Endocrinology, 24, 135 140. (Pubitemid 16160978)
16. Dauncey, M.J., Shakespear, R.A., Rudd, B.T. et al. (1990) Variations in somatomedin-C/insulin-like growth factor-I associated with environmental temperature and nutrition. Hormone and Metabolic Research, 22, 261 264. (Pubitemid 20158774)
17. Bland, J.M. Altman, D.G. (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet, 1, 307 310. (Pubitemid 16134762)
18. Jayasena, C.N., Wujanto, C., Donaldson, M. et al. (2008) Measurement of basal growth hormone (GH) is a useful test of disease activity in treated acromegalic patients. Clinical Endocrinology, 68, 36 41. (Pubitemid 350243479)
19. Bates, A.S., Evans, A.J., Jones, P. et al. (1995) Assessment of GH status in acromegaly using serum growth hormone, serum insulin-like growth factor-1 and urinary growth hormone excretion. Clinical Endocrinology, 42, 417 423.
20. Jenkins, D., O'Brien, I., Johnson, A. et al. (1995) The Birmingham pituitary database: auditing the outcome of the treatment of acromegaly. Clinical Endocrinology, 43, 517 522.
21. Parfitt, V.J., Flanagan, D., Wood, P. et al. (1998) Outpatient assessment of residual growth hormone secretion in treated acromegaly with overnight urinary growth hormone excretion, random serum growth hormone and insulin like growth factor-1. Clinical Endocrinology, 49, 647 652. (Pubitemid 28529764)
22. Bajuk Studen, K. Barkan, A. (2008) Assessment of the magnitude of growth hormone hypersecretion in active acromegaly: reliability of different sampling models. Journal of Clinical Endocrinology and Metabolism, 93, 491 496. (Pubitemid 351240821)
23. Gullu, S., Keles, H., Delibasi, T. et al. (2004) Remission criteria for the follow-up of patients with acromegaly. European Journal of Endocrinology, 150, 465 471. (Pubitemid 38584696)
24. Kaltsas, G.A., Isidori, A.M., Florakis, D. et al. 2001) Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity. Journal of Clinical Endocrinology and Metabolism, 86, 1645 52.
25. Freda, P.U., Nuruzzaman, A.T., Reyes, C.M. et al. (2004) Significance of 'abnormal' nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels. Journal of Clinical Endocrinology and Metabolism, 89, 495 500. (Pubitemid 38269847)
26. Freda, P.U. (2003) Current concepts in the biochemical assessment of the patient with acromegaly. Growth Hormone and IGF Research, 13, 171 184. (Pubitemid 36980706)
27. Holdaway, I.M. Rajasoorya, C. (1999) Epidemiology of acromegaly. Pituitary, 2, 29 41.
28. Thissen, J.P., Ketelslegers, J.M. Underwood, L.E. (1994) Nutritional regulation of the insulin-like growth factors. Endocrine Reviews, 15, 80 101. (Pubitemid 24058597)
29. Leung, K.C., Johannsson, G., Leong, G.M. et al. (2004) Estrogen regulation of growth hormone action. Endocrine Reviews, 25, 693 721. (Pubitemid 39366048)
30. Gibney, J., Healy, M.L. Sonksen, P.H. (2007) The growth hormone/insulin-like growth factor-I axis in exercise and sport. Endocrine Reviews, 28, 603 624. (Pubitemid 47610444)
31. Peacey, S.R., Toogood, A.A. Shalet, S.M. (1998) Hypothalamic dysfunction in 'cured' acromegaly is treatment modality dependent. Journal of Clinical Endocrinology and Metabolism, 83, 1682 1686. (Pubitemid 28501042)
32. Peacey, S.R., Toogood, A.A., Veldhuis, J.D. et al. (2001) The relationship between 24-h growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy. Journal of Clinical Endocrinology and Metabolism, 86, 259 266. (Pubitemid 32109805)
33. Brooke, A.M. Drake, W.M. (2007) Serum IGF-I levels in the diagnosis and monitoring of acromegaly. Pituitary, 10, 173 179. (Pubitemid 46863732)
34. Waugh, N., Scotland, G., McNamee, P. et al. (2007) Screening for type 2 diabetes: literature review and economic modelling. Health Technology Assessment, 11, iii iv, ix xi, 1 125.
35. Stewart, P.M. (2000) Current therapy for acromegaly. Trends in Endocrinology and Metabolism, 11, 128 132. (Pubitemid 30238544)